Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease☆
References (23)
Genetic and biochemical aspects of Wilson's disease
Amer. J. Med.
(1953)Wilson's disease. An inborn error of metabolism with multiple manifestations
Amer. J. Med.
(1957)- et al.
Study on copper metabolism. XXIX
Amer. J. Med.
(1960) - et al.
Wilson's disease and the concentration of ceruloplasmin in serum
Lancet
(1963) Penicillamine, a new oral therapy for Wilson's disease
Amer. J. Med.
(1956)Genetic considerations in Wilson's disease
- et al.
Wilson's disease
Ann. Rev. Med.
(1965) Lancet: Search for the heterozygote in Wilson's disease
(1963)A genetic, biochemical and clinical study of Wilson's disease among Chinese in Taiwan
Acta Paediat. Sinica
(1963)- et al.
Microdetermination of copper in biological material
Biochem. J.
(1940)
The metabolic disorder in hepato-lenticular degeneration
Quart. J. Med.
Cited by (38)
Wilson disease
2019, Seminars in Diagnostic PathologyWilson's disease: A master of disguise
2019, Parkinsonism and Related DisordersCitation Excerpt :The 24-h urine copper values below this cutoff exclude WD. Intermediate values between 50 and 100 μg/24 h may be seen in heterozygous (carrier) individuals and require further investigation [3,37]. Affected symptomatic children with WD may also have 24-H urine copper values below the conventional cutoff and lowering this value in pediatric patients has been suggested.
Diagnosis of Hepatic Wilson Disease
2019, Wilson Disease: Pathogenesis, Molecular Mechanisms, Diagnosis, Treatment and MonitoringBiochemical Markers
2019, Wilson Disease: Pathogenesis, Molecular Mechanisms, Diagnosis, Treatment and MonitoringBiochemical diagnosis of Wilson disease
2018, Clinical and Translational Perspectives on WILSON DISEASEDiagnosis of Wilson disease
2017, Handbook of Clinical Neurology
- ☆
This study was supported in part by funding under U. S. Public Law 480, Section 104 (c).
- 1
Jun-Bi Tu, M.D.: Instructor, Department of Neurology and Psychiatry, National Taiwan University Hospital, and Medical Research Fellow in Departments of Biochemistry and Clinical Investigation, U. S. Naval Medical Research Unit No. 2, Taipei, Taiwan, Republic of China.
- 2
R. Quentin Blackwell, Ph.D.: Head, Department of Biochemistry, U. S. Naval Medical Research Unit No. 2, Taipei, Taiwan, Republic of China. Mailing Address: Box 14, APO San Francisco 96263.